Tag: Teva

Teva acquires Emalex Biosciences for as much as $900m

by whysavetoday

April 29, 2026

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) right this moment introduced it has signed a definitive settlement to ...

Teva provides aggressive steerage for modern medicine

by whysavetoday

May 31, 2025

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) held an "Innovation and Technique Day" as we speak, wherein it ...

Teva experiences sturdy Q2 outcomes, raises 2024 forecast

by whysavetoday

August 1, 2024

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) reported sturdy outcomes for the second quarter of 2024 and once ...

About Us

At Why Save Today, we are dedicated to bringing you the latest insights and trends in the world of finance, investment, and business. Our mission is to empower our readers with the knowledge and tools they need to make informed financial decisions, achieve their investment goals, and stay ahead in the ever-evolving business landscape.

Tag: Teva

Teva acquires Emalex Biosciences for as much as $900m

Teva provides aggressive steerage for modern medicine

Teva experiences sturdy Q2 outcomes, raises 2024 forecast

Recent

International insurers retain capital in extreme 1-in-250 disaster

Shares End Larger on Stable Earnings and a Resilient Labor Market

Fortune 500 CEO Lists His Double-Sized ‘Property Within the Sky’ for $20 Million

Categories

About Us

Category

Recent Post